G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Director of Analytical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeFoster City, CA, USA

About the Job

Requirements

  • A Ph.D. in Analytical Chemistry, Pharmaceutical Sciences, or a related discipline with 8+ years of relevant pharmaceutical or biotech analytical development experience; alternatively, 10+ years with an MS or 12+ years with a BS.
  • At least 5 years of people management experience, including directing managers and leading sizeable teams.
  • Demonstrated expertise in small-molecule analytical development and technology innovation across the full development lifecycle, including early- and late-stage development and commercial support.
  • Deep working knowledge of ICH guidelines (Q1, Q2, Q3, Q6A, Q14, M4, M7), cGMP requirements, and global regulatory expectations.
  • Experience contributing to regulatory submissions (IND/CTA, NDA/MAA) and responding to questions from global health authorities.
  • Experience with complex dosage forms (e.g., API, fixed-dose combinations, modified release, sterile injectables) or specialized modalities.
  • Ability to understand and apply scientific concepts and methods across multiple subject areas, including chemistry, pharmaceutical sciences, process analytical technology (PAT), and modeling/simulation.
  • Experience with pre-approval inspections (PAI) and commercial lifecycle management, including post-approval changes and ICH Q12.
  • Experience building or restructuring analytical organizations, including LIMS/ELN and digital lab initiatives.
  • Demonstrated strategic thinking and portfolio prioritization; scientific judgment under ambiguity; talent development; stakeholder management; decision-making in cross-functional governance settings; and written and verbal communication for executive and regulatory audiences.

Responsibilities

  • Lead, mentor, and develop a team of scientists defining end-to-end analytical development strategies, from raw materials through drug product, across the portfolio’s pre-clinical, clinical, and commercial lifecycle. Strategies include control of process impurities, degradants, mutagenic impurities per ICH M7, nitrosamines, and elemental impurities per ICH Q3D.
  • Partner with Research, Regulatory Affairs, Process Chemistry, Formulation, Quality, and Manufacturing to align control strategies with process and product understanding and regulatory expectations.
  • Drive development, implementation, and continuous improvement of analytical methodologies and technologies, including HPLC/UPLC, GC, dissolution, KF, spectroscopy, and particle-size analysis, aligned with ICH guidelines and phase-appropriate development needs.
  • Guide technical transfer to internal QC laboratories and support method development and technical transfer to external partners (CDMOs/CTLs).
  • Direct development stability strategy and support GMP stability programs (ICH Q1A–Q1E), including shelf-life setting and stability data interpretation.
  • Champion modern approaches, including analytical QbD (ICH Q14), enhanced method development, and data integrity best practices.
  • Direct innovation of analytical technologies to improve productivity and increase product and process understanding.
  • Serve as cross-functional team leader; participate in governance and technical review committees; and contribute to portfolio-level CMC strategy and risk assessment.
  • Author, review, and approve analytical sections of regulatory submissions (IND/IMPD, NDA/MAA, amendments, and responses to health authority questions).
  • Represent Analytical Development in health authority interactions and pre-approval/pre-license inspections.
  • Operate within the departmental budget and manage resource allocation and prioritization across a multi-program portfolio.
  • Foster a culture of scientific rigor, quality, inclusion, and continuous improvement.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs